Drug Provision of Persons Suffering With Iodine and Iron Deficiency Under the Additional Program of Compulsory Health Insurance in the Kyrgyz Republic

Abstract

In recent years, interest in the problem of treatment and prevention of iodine and iron deficiency has increased, as their prevalence is becoming wider, and the clinical course is more severe. According to the results of medical and demographic studies, most of the country’s population is at risk of developing a deficiency in the intake of iodine and iron, which makes the treatment of iodine and iron deficiency conditions one of the most important medical and social problems for the health care of Kyrgyzstan. The purpose of the study is to study preferential drug provision for people suffering from iodine and iron deficiency conditions, within the framework of an additional program of compulsory medical insurance in the Kyrgyz Republic. Materials and research methods. Data from the Compulsory Medical Insurance Fund under the Ministry of Health of the Kyrgyz Republic. Content analysis, graphical and statistical methods. Research results. The main number of preferential prescriptions for iodine and iron deficiency under the Additional Program of Compulsory Medical Insurance was issued in the southern regions of Kyrgyzstan. The leaders in the number of prescriptions for iodine-containing preparations are preparations under the trade names Iodomarin and Iodbalance, and for iron-containing preparations — the preparation of the pharmaceutical company Sandoz (Republic of Slovenia) under the trade name Ferrum — chewable tablets. The categories of insured citizens “Pregnant women”, “Students” and “Children” have the smallest shares of preferential prescriptions for iodine-deficiency diseases. These categories of citizens belong to socially vulnerable segments of the population, where a low prescription for iodine-containing drugs can adversely affect their health, and also increases the possible risks of various malformations in the fetus. The results of this study will help assess the effectiveness of the functioning of the Additional Program of Compulsory Medical Insurance in the treatment of iodine and iron deficiency conditions, determine the amount of funding for this program in different regions of the country, as well as draw attention to the need for preventive measures and broader awareness of the population about the need for iodine and iron deficiency condition prevention.